Shares of Eli Lilly (LLY) and Novo Nordisk (NVO) fell on Friday after the companies agreed to offer their blockbuster weight-loss drugs at sharply discounted prices in the U.S. as part of a major drug ...
Invesco highlights quality growth opportunities amid global volatility, favoring adaptable international stocks. See why now ...
Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback